What year was Nucynta (tapentadol) approved by the FDA?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Nucynta FDA Approval Year

Nucynta (tapentadol) was approved by the FDA in November 2008 for the treatment of moderate-to-severe acute pain in adults. 1, 2

Initial Approval Details

  • The immediate-release formulation of tapentadol was the first new centrally acting analgesic approved by the FDA in 2008, representing a novel class of analgesics with dual mechanism of action 2

  • The drug was classified as a Schedule II controlled substance (C-II) at the time of its initial approval 1

Subsequent Formulation Approvals

  • Extended-release tapentadol (Nucynta ER) was subsequently approved in August 2011 for chronic pain management requiring continuous, around-the-clock opioid treatment 3, 4

  • The extended-release formulation was later approved for treatment of chronic painful diabetic neuropathy 5

Available Formulations

  • Immediate-release tablets are available in 50 mg, 75 mg, and 100 mg strengths for acute pain management 1, 5

  • Extended-release tablets are available in 50 mg, 100 mg, 150 mg, 200 mg, and 250 mg strengths for chronic pain conditions 5

Related Questions

What are some new pain management medications?
Is tapentadol (a dual-action opioid analgesic) the same as fentanyl (a potent opioid agonist)?
What is the recommended dosage and usage of Tapentadol (generic name) for pain management?
What is the information about Nucynta (tapentadol)?
What are the pharmacodynamics and pharmacokinetics of tapentadol (a centrally acting analgesic) in patients with potential substance abuse, respiratory problems, and impaired renal function?
What is the best antibiotic for a patient with a dental or ear infection who is allergic to penicillin (PCN)?
I had an HIV exposure one year ago, tested negative with 4th generation (fourth-generation) tests at multiple time points, viral load, qualitative RNA (ribonucleic acid) PCR (polymerase chain reaction), and Western blot, and also tested negative for Hepatitis C and HBsAg (hepatitis B surface antigen), but experienced severe flu-like symptoms and abdominal cramps, and took PEP (post-exposure prophylaxis), could I still have an HIV infection or is there another cause for my symptoms?
What are the causes of laryngitis posterior, especially in adults with a history of smoking or exposure to respiratory irritants?
What is the appropriate dosing regimen for vancomycin (Vancomycin) in adults with varying degrees of renal function, including those with normal renal function and impaired renal function?
What are the World Health Organization (WHO) parameters for a normal semen analysis in adult males of reproductive age?
What is plasmapheresis (plasma exchange) and are they the same process, particularly in patients with severe autoimmune disorders?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.